BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28061760)

  • 1. Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics.
    Backholer K; Hirakawa Y; Tonkin A; Giles G; Magliano DJ; Colagiuri S; Harris M; Mitchell P; Nelson M; Shaw JE; Simmons D; Simons L; Taylor A; Harding J; Gopinath B; Woodward M
    BMC Cardiovasc Disord; 2017 Jan; 17(1):17. PubMed ID: 28061760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
    Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study.
    Nelson MR; Ryan P; Tonkin AM; Ramsay E; Willson K; Wing LW; Reid CM;
    Hypertension; 2010 Jul; 56(1):44-8. PubMed ID: 20497992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
    Petersson U; Ostgren CJ; Brudin L; Nilsson PM
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 7. [Model for estimation of cardiovascular risk in Norway].
    Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study.
    Sprengers RW; Janssen KJ; Moll FL; Verhaar MC; van der Graaf Y;
    J Vasc Surg; 2009 Dec; 50(6):1369-76. PubMed ID: 19837547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study.
    Graversen P; Abildstrøm SZ; Jespersen L; Borglykke A; Prescott E
    Eur J Prev Cardiol; 2016 Sep; 23(14):1546-56. PubMed ID: 26976846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged population.
    Huynh QL; Reid CM; Chowdhury EK; Huq MM; Billah B; Wing LM; Tonkin AM; Simons LA; Nelson MR;
    Am J Hypertens; 2015 May; 28(5):649-56. PubMed ID: 25399017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study.
    Barr EL; Reutens A; Magliano DJ; Wolfe R; Lu ZX; Sikaris KA; Tanamas SK; Atkins R; Chadban S; Shaw JE; Polkinghorne KR
    Nephrology (Carlton); 2017 Mar; 22(3):243-250. PubMed ID: 26938304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive modeling of health care costs: do cardiovascular risk markers improve prediction?
    Baumeister SE; Dörr M; Radke D; Nauck M; John U; Marschall P; Flea S; Schmidt CO; Alte D; Völzke H
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):355-62. PubMed ID: 19907337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Validity of the American College of Cardiology/American Heart Association Pooled Cohort Equations in Predicting All-Cause and Cardiovascular Disease-Specific Mortality in a National Prospective Cohort Study of Adults in the United States.
    Loprinzi PD; Addoh O
    Mayo Clin Proc; 2016 Jun; 91(6):763-9. PubMed ID: 27180122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan.
    Nakai M; Watanabe M; Kokubo Y; Nishimura K; Higashiyama A; Takegami M; Nakao YM; Okamura T; Miyamoto Y
    J Atheroscler Thromb; 2020 Nov; 27(11):1160-1175. PubMed ID: 32023562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.
    Cui J; Forbes A; Kirby A; Simes J; Tonkin A
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):660-8. PubMed ID: 19738473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project.
    Hata J; Nagai A; Hirata M; Kamatani Y; Tamakoshi A; Yamagata Z; Muto K; Matsuda K; Kubo M; Nakamura Y; ; Kiyohara Y; Ninomiya T
    J Epidemiol; 2017 Mar; 27(3S):S71-S76. PubMed ID: 28142037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalibration of the SCORE risk chart for the Russian population.
    Jdanov DA; Deev AD; Jasilionis D; Shalnova SA; Shkolnikova MA; Shkolnikov VM
    Eur J Epidemiol; 2014 Sep; 29(9):621-8. PubMed ID: 25179794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
    Friis-Møller N; Ryom L; Smith C; Weber R; Reiss P; Dabis F; De Wit S; Monforte AD; Kirk O; Fontas E; Sabin C; Phillips A; Lundgren J; Law M;
    Eur J Prev Cardiol; 2016 Jan; 23(2):214-23. PubMed ID: 25882821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.